Meta Pixel

News and Announcements

BPS Technology Announces Exceeding Expectations and Record Revenues

  • Published June 30, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

BPS Technology Limited (“Company”, “BPS” or “BPS Technology”) today announces the following key developments and updates:

KEY TAKEAWAYS:

  • Entertainment Publications (Entertainment) exceeding expectations and on track for record revenues
  • Agreement to onboard BPS’ 17,000 relevant merchants in Australia on to the Alibaba Australia eCommerce platform
  • Commencement of operations in France
  • Significant new agreements entered into by Frequent Values, a division of Entertainment
  • Financial performance and revised earnings before interest, tax, depreciation and amortisation (EBITDA) guidance for FY17

The initiatives above represent further important steps in the evolution of BPS Technology. An overview of these developments, along with updated financial guidance, has been provided below.

More Information

Request Information 

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now